Anatomic pathology services at UPMC CancerCenter focus largely on the roles of:
As well as the routine processing of tumor resections, we've refined molecular diagnostic techniques to detect minimal residual disease and the stages of tumor progression.
We carry out many such complex analyses for hematologic neoplasms and solid tumors. This allows us to offer both diagnostic and treatment input into patient services.
The In-Situ Hybridization Lab employs molecular diagnostic techniques to study solid tumor expression of:
Fluorescent in-situ hybridization techniques use a fluorescent probe to look at a specific portion of DNA. This helps us find gene mutations and apply antibodies to oncoproteins produced by overexpressed oncogenes.
We use this technique to study cancerous tumors of the:
The Molecular Anatomic Pathology Section at UPMC CancerCenter studies solid tumor specimens, both fresh and fixative treated.
We employ advanced techniques to detect and describe these mutations to use for both diagnosis and treatment planning.
This knowledge allows us to separate tumors into different groups based on how they behave and respond to specific chemotherapy regimens. Vital to this effort is tissue microdissection using tools such as laser capture to optimize sample selection for molecular analysis.
This work is among the most advanced in the nation used for both research studies and clinical testing.